Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 30, 2011 07:30 ET | Source: NephRx Corporation

NephRx Corp. Awarded U.S. Patent for NX002 for Treatment of Oral Mucositis

Second Patent Highlights Potential Broad Utility of Novel Growth Factor Peptide NX002 for Treatment of Oral Mucositis and Other GI Disorders Initiation of Detailed Toxicology Studies Targeted for...